Intramedullary Bone Grafting for Open Tibial Shaft Fractures
Launched by UNIVERSITY OF LOUISVILLE · Mar 26, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective a specific treatment is for patients with open fractures of the tibia, which is the larger bone in your lower leg. The trial will compare two groups of patients who are undergoing a common surgery called intramedullary nailing to fix their fractures. One group will receive an additional treatment called a bone graft, which is made from the leftover bone material during the surgery. The main goal is to see if this bone graft helps patients heal faster and achieve full union of the fracture compared to those who do not receive the graft.
To be eligible for this study, participants must be at least 18 years old and have a certain type of open tibia fracture that will be treated with intramedullary nailing. They should also be able to return for follow-up visits for about 6 to 9 months to monitor their healing. Patients who are pregnant, under 18, or have certain complications related to their fractures may not be able to participate. If you join the study, you can expect close monitoring of your recovery and the chance to contribute to important research that could improve treatment for future patients with similar injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient age 18 or older
- • Patient with a Gustillo I, II, or IIIa open tibia shaft fracture to be treated primarily with an intramedullary nail
- • Primary closure of the open fracture wound during the initial operation
- • Consent to participate in the study.
- • Are able and willing to return to the hospital or clinic for follow-up for a period of 6-9 months or until radiographic union.
- Exclusion Criteria:
- • Patients under the age of 18.
- • Patients who are pregnant
- • Patients with segmental tibia fractures or those with loss of bone
- • Patients with skin defects over the tibia that cannot be closed primarily
- • Patients with a pathologic fracture of the tibia
- • Patient has quadriplegia or paraplegia
About University Of Louisville
The University of Louisville is a distinguished academic institution known for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct pioneering studies that aim to improve patient outcomes and enhance healthcare practices. With a focus on interdisciplinary collaboration and community engagement, the University of Louisville fosters an environment conducive to groundbreaking research across various medical fields, ensuring adherence to the highest ethical standards and regulatory compliance. Through its clinical trials, the university seeks to translate scientific discoveries into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Louisville, Kentucky, United States
Patients applied
Trial Officials
Rodolfo Zamora, MD
Principal Investigator
University of Louisville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials